Neo Life Sciences Logo
040-35247813•Hyderabad, India
EVENT FEATURE • iPHEX 20266 Min Read•September 2026

iPHEX 2026 — Powering Healthcare. Connecting Markets.

Neo Life Sciences Pvt. Ltd. (formerly known as Neo Ayushveda) proudly engaged with global delegates, regulatory authorities and international buyers at India’s flagship pharmaceutical exhibition, fostering meaningful connections and exploring global business opportunities.

Neo Life Sciences Corporate Media

Published from Pragati Maidan, New Delhi

Featured Expo

iPHEX 2026

Dates

7 – 9 September 2026

Venue

Bharat Mandapam

Hall & Stall

Hall: 3FF • Stall: 3FC-07

Organized By

Pharmexcil

PHOTO SHOWCASE • INAUGURATION & MINISTERIAL KEYNOTES

The Opening Summit at Bharat Mandapam

iPHEX 2026 Opening Ceremony
INAUGURATION

iPHEX 2026 Opening Ceremony

Inauguration of iPHEX 2026, by Hon’ble Union Minister for Commerce & Industry – Mr. Piyush Goyal through the traditional lighting of the ceremonial lamp. bringing together industry leaders, policymakers, pharmaceutical manufacturers and global healthcare stakeholders, setting the stage for three days of meaningful industry engagement and international collaboration

By Minister of State for Commerce and Industry – Mr. Jitin Prasada
KEY NOTE ADDRESS

By Minister of State for Commerce and Industry – Mr. Jitin Prasada

Global Healthcare Dialogue
POLICY & INDUSTRY

Global Healthcare Dialogue

Neo Life Sciences Pvt. Ltd. (formerly known as Neo Ayushveda) marked an impactful presence at the prestigious 12th edition of iPHEX 2026, organized by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) under the Ministry of Commerce & Industry, Government of India.

Convened at the state-of-the-art Bharat Mandapam convention complex in Pragati Maidan, New Delhi, the 3-day international summit brought together over 10,000 healthcare leaders, government delegates, institutional buyers, and pharmaceutical innovators from across 120 nations. The summit serves as the primary bridge connecting Indian formulation excellence with the escalating healthcare requirements of emerging and regulated markets globally.

CHAPTER 1 • POLICY, INNOVATION & NATIONAL MANDATE

Upholding India’s Role as the “Pharmacy of the World”

The exhibition commenced with the traditional ceremonial lighting of the lamp by Hon’ble Union Minister for Commerce & Industry, Mr. Piyush Goyal, who reaffirmed the government’s unwavering commitment to empowering Indian manufacturers in advancing global healthcare access.

“Trust, innovation, partnership, and equitable global access remain our core pillars. The Indian pharmaceutical sector continues to push R&D, patent indigenous formulations, and scale biosimilars for the world.”

Hon’ble Union Minister Mr. Piyush GoyalMinistry of Commerce & Industry

In his keynote address, Minister of State for Commerce & Industry, Mr. Jitin Prasada, aptly designated iPHEX as the “Mother of All Exhibitions”, underscoring that global supply chains increasingly rely upon India’s robust manufacturing ethics, regulatory compliance, and cost-efficient generic therapies.

“Greater global collaboration in pharmaceuticals and healthcare will fortify healthcare systems across borders. India stands steadfast as the trusted Pharmacy of the World.”

Mr. Jitin PrasadaMinister of State for Commerce & Industry
CHAPTER 2 • CROSS-BORDER TRADE & STRATEGIC NETWORKING

Accelerating B2B Buyer Engagements Across 50+ Countries

A defining cornerstone of Neo Life Sciences’ presence at iPHEX was an exhaustive series of scheduled and walk-in buyer-seller meetings. Delegations from the Middle East, West Asia & North Africa (WANA), Southeast Asia, Africa, and CIS nations engaged with our corporate leadership to evaluate long-term procurement frameworks.

International Buyer Engagement#4 • B2B NETWORKING

International Buyer Engagement

Connecting with international delegates and business representatives to explore pharmaceutical sourcing and distribution opportunities for Neo.

International Business Connections#5 • B2B NETWORKING

International Business Connections

Building meaningful relationships with international healthcare professionals and exploring opportunities for global collaboration, especially in WANA countries.

International delegates placed particular emphasis on regulatory documentation and dossier support. Neo Life Sciences demonstrated comprehensive capability in delivering ready-to-file Common Technical Document (CTD) and ACTD dossiers, facilitating rapid market registrations in emerging healthcare jurisdictions where regulatory frameworks are progressively harmonizing with international standards.

Connecting Across Markets#6 • GLOBAL NETWORKING

Connecting Across Markets

Strengthening international business relationships through discussions with global pharmaceutical stakeholders.

Bilateral Business Discussions#7 • B2B MEETINGS

Bilateral Business Discussions

Engaging in focused discussions with international delegates to understand market requirements and explore potential partnerships.

CHAPTER 3 • EXHIBITION SHOWCASE & CLIENT DIALOGUE

Inside Hall 3FF • Stall 3FC-07: Showcasing Product Excellence

Located in Hall 3FF, our exhibition stall served as an energetic focal point for international distributors, hospital procurement heads, and pharmaceutical formulators. We showcased our complete spectrum of WHO-GMP certified generic solid orals, liquid dosages, injectables, APIs, and standardized herbal extracts.

Neo Life Sciences at iPHEX 2026#8 • EXHIBITION HIGHLIGHTS

Neo Life Sciences at iPHEX 2026

Showcasing our pharmaceutical sourcing and export capabilities to visitors and international delegates at our exhibition stall.

Building Relationships Beyond Business#9 • CUSTOMER ENGAGEMENT

Building Relationships Beyond Business

Creating meaningful connections with customers and partners across global markets.

Direct engagement at our booth enabled visitors to evaluate sample packaging, verify batch stability documentation, and explore private-label contract manufacturing arrangements tailored to regional market volume requirements.

Pharmaceutical Business Discussions#10 • BUYER–SELLER MEET

Pharmaceutical Business Discussions

Discussing healthcare requirements, product portfolios and potential business opportunities with prospective partners.

Focused Business Meetings#11 • B2B NETWORKING

Focused Business Meetings

Productive discussions with industry professionals focused on pharmaceutical sourcing, market opportunities and collaboration.

EXHIBITION STRATEGIC TAKEAWAYS

Key Outcomes from iPHEX 2026

Neo Life Sciences concluded the 3-day exhibition with tangible commercial momentum and fortified institutional partnerships across high-demand export destinations.

100+Buyer Consultations Initiated
50+Target Export Markets Represented
100%CTD / ACTD Dossier Readiness
COMPLETE ARCHIVE

iPHEX 2026 Photographic Archive

All 11 official event photographs chronologically captured from the opening ceremony to closing B2B delegations. Click on any photo to inspect in full resolution.

iPHEX 2026 Opening Ceremony
INAUGURATION

iPHEX 2026 Opening Ceremony

#01
By Minister of State for Commerce and Industry – Mr. Jitin Prasada
KEY NOTE ADDRESS

By Minister of State for Commerce and Industry – Mr. Jitin Prasada

#02
Global Healthcare Dialogue
POLICY & INDUSTRY

Global Healthcare Dialogue

#03
International Buyer Engagement
B2B NETWORKING

International Buyer Engagement

#04
International Business Connections
B2B NETWORKING

International Business Connections

#05
Connecting Across Markets
GLOBAL NETWORKING

Connecting Across Markets

#06
Bilateral Business Discussions
B2B MEETINGS

Bilateral Business Discussions

#07
Neo Life Sciences at iPHEX 2026
EXHIBITION HIGHLIGHTS

Neo Life Sciences at iPHEX 2026

#08
Building Relationships Beyond Business
CUSTOMER ENGAGEMENT

Building Relationships Beyond Business

#09
Pharmaceutical Business Discussions
BUYER–SELLER MEET

Pharmaceutical Business Discussions

#10
Focused Business Meetings
B2B NETWORKING

Focused Business Meetings

#11
GLOBAL TRADE DESK

Partner with Neo Life Sciences for Global Pharma Sourcing

Discuss WHO-GMP finished formulations, custom generic manufacturing, and regulatory dossier filings with our international export division.